Tempus AI to Acquire Personalis in $16.25-Per-Share Deal to Expand MRD Testing and Biopharma Data Capabilities

Tempus AI Inc. (NASDAQ: TEM) announced it will purchase all outstanding shares of Personalis Inc. (PSNL) that it does no...

Read story →